Deep Brain Stimulation May Ease Some of Common Urinary Problems in Parkinson’s Patients, Study Reports
Deep brain stimulation (DBS) can help to alleviate some urinary symptoms — such as urinary frequency, urgency, and incontinence…
Articles by Catarina Silva, MSc
Lewy Bodies Are Made of Much More than Alpha-Synuclein, Study Finds
Insoluble alpha-synuclein protein has long been thought to be the main component of Parkinson’s hallmark Lewy bodies, but researchers…
Cellular Respiration Compound May Ease Symptoms, Reduce Neuronal Loss, Study Finds
Delivering a compound called nicotinamide adenine dinucleotide to the striatum, a key brain region involved in motor control, can…
Participants Sought for Clinical Trial Testing ENT-01 for Parkinson’s Dementia
Enterin Inc has enrolled the first patient in its Phase 1b DEMET clinical trial investigating the effectiveness, safety and…
AV-101 Reduces Parkinson’s Dyskinesia Without Amantadine Side Effects, Preclinical Study Suggests
VistaGen Therapeutics’ candidate, AV-101, reduced levodopa-induced dyskinesia (abnormal involuntary movements) while maintaining levodopa activity in a non-human primate…
Dietary Supplement Eases Parkinson’s Symptoms, Improves Dopamine Function, Study Shows
N-acetyl-cysteine (NAC), a compound that is used by the body to produce an antioxidant called glutathione, may improve dopamine function…
Sleep Deprivation May Amplify Cognitive and Emotional Issues in Parkinson’s, Study Finds
Not getting enough sleep may cause memory defects and emotional changes in Parkinson’s disease due to changes in dopamine…
Man-made DNA Molecules May Help Prevent Parkinson’s, Study Finds
Osaka University scientists have built short fragments of DNA that can stop the production of abnormal alpha-synuclein protein in…
Molecule May Halt Parkinson’s Progression, Study Using New Mouse Model Finds
A molecule called anle138b was able to reduce toxic alpha-synuclein aggregates, or clumps, in the brain — a key…
Zonisamide with Levodopa May Reduce Risk of Dementia, Other Parkinson’s-related Symptoms, Japanese Study Suggests
Japanese researchers have reported that zonisamide — an antiparkinsonian medicine approved in Japan as a combination therapy with levodopa…